Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TNFRSF8 antibody

The Mouse Monoclonal anti-TNFRSF8 antibody (Clone CD30-412) (ABIN6941146) specifically detects TNFRSF8 in IHC. The antibody is reactive with Human samples.
Catalog No. ABIN6941146
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for TNFRSF8 antibody (ABIN6941146)

Target

See all TNFRSF8 Antibodies
TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

Reactivity

  • 198
  • 38
  • 20
  • 16
Human

Host

  • 112
  • 101
  • 14
  • 6
  • 1
  • 1
  • 1
Mouse

Clonality

  • 160
  • 74
  • 2
Monoclonal

Conjugate

  • 101
  • 18
  • 16
  • 13
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
This TNFRSF8 antibody is un-conjugated

Application

  • 121
  • 90
  • 72
  • 47
  • 39
  • 34
  • 27
  • 26
  • 14
  • 7
  • 7
  • 6
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

CD30-412
  • Purpose

    CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) Antibody

    Specificity

    Recognizes a single chain glycoprotein of 105/120kDa, identified as CD30/Ki-1. CD30 is synthesized as a 90kDa precursor, which is processed in the Golgi complex into a membrane-bound phosphorylated mature 105/120kDa glycoprotein. In Hodgkin's disease, CD30/Ki-1 antigen is expressed by mononuclear-Hodgkin and multinucleated Reed-Sternberg cells. It is also expressed by the tumor cells of a majority of anaplastic large cell lymphomas as well as by a varying proportion of activated T and B cells. This MAb distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas. About one third of the Ki-1 positive lymphomas lack the leukocyte common antigen (CD45).

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Human CD30 recombinant protein

    Isotype

    IgG1, kappa
  • Application Notes

    Positive Control: Hodgkin's lymphoma.

    Known Application: Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 1 mM EDTA, pH 7.5-8.5, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

    Alternative Name

    TNFRSF8

    Background

    CD30L receptor, Cytokine receptor CD30, Ki-1 antigen, Lymphocyte activation antigen CD30, Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)

    Hodgkin's lymphoma.

    Molecular Weight

    105-120kDa

    Gene ID

    943, 1314

    UniProt

    P28908
You are here:
Chat with us!